You just read:

Celtic Pharma Announces Preclinical Findings that XERECEPT(R) Potentiates Significantly the Tumor Inhibition Activity of Avastin(R)

News provided by

Celtic Pharmaceutical Holdings L.P.

Apr 19, 2010, 09:44 ET